News

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The Pharma Letter7h
The week in pharma: action, reaction and insight – week to June 13
Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...